Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome

Hematology

Volumn 11, Issue 3, 2006, Pages 179-181

  Ashida, Takashi ^a   Mayama, Takashi ^a   Higashishiba, Masaki ^a   Kawanishi, Kazunobu ^a   Miyatake, Junichi ^a   Tatsumi, Yoichi ^a   Kanamaru, Akihisa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute graft versus host disease; Myelodysplastic syndrome; Reduced intensity stem cell transplantation; Sweet' syndrome

Indexed keywords

ACLARUBICIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CORTICOSTEROID; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISOLONE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DRUG RESPONSE; HISTOPATHOLOGY; HLA MATCHING; HUMAN; HUMAN TISSUE; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REFRACTORY ANEMIA; REMISSION; SKIN BIOPSY; STEM CELL TRANSPLANTATION;

ACLARUBICIN; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANTI-INFLAMMATORY AGENTS; BONE MARROW TRANSPLANTATION; BUSULFAN; COMBINED MODALITY THERAPY; CYTARABINE; DRUG THERAPY, COMBINATION; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; REMISSION INDUCTION; SWEET SYNDROME; SWEET'S SYNDROME; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 33748514368     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600667492     Document Type: Article

References (9)

1. Sweet, RD. (1964) An acute febrile neutrophilic dermatosis Br J Dermatol, 76, pp. 346-349.
2. Reuss-Borst, MA and Pawelec, G and Saal, JC and Horny, HP and Muller, CA and Waller, HD. (1993) Sweet's syndrome associated with myelodysplasia: Possible role of cytokines in the pathogenesis of the disease Br J Haematol, 84, pp. 356-358.
3. Kurznock, R and Cohen, PR. (1995) Mucocutaneous paraneoplastic manifestations of hematologic malignancies Am J Med, 99, pp. 207-216.
4. Avivi, I and Rosenbaum, H and Levy, Y and Rowe, J. (1999) Myelodysplastic syndrome and associated skin lesions: A review of the literature Leuk Res, 23, pp. 323-330.
5. van den Driesch, P and Steffan, C and Zobe, A and Hornstein, OP. (1994) Sweet's syndrome: Therapy with cyclosporine A Clin Exp Dermatol, 19, pp. 274-277.
6. Cohen, PR and Tarpaz, M and Kurzrock, R. (1988) Malignancy associated Sweet's syndrome: Review of the world literature J Clion Oncol, 6, pp. 1887-1897.
7. Park, JW and Mehrotra, B and Barnett, BO and Baron, AD and Venook, AP. (1992) Sweet's syndrome during therapy with granulocute colony-stimulating factor Ann Intern Med, 116, pp. 996-998.
8. Cohen, PR and Holder, WR and Tucker, SB and Kono, S and Kurzrock, R. (1993) Sweet's syndrome in patients with solid tumors Cancer, 72, pp. 2723-2731.
9. Cohen, PR and Kurzrock, R. (2002) Sweet's syndrome: A review of current treatment options Am J Clin Dermatol, 3, pp. 117-131.